BSEM 8-K 2026-08-07

BioStem Technologies, Inc. (BSEM) 8-K dated 2026-08-07 — accession 0001193125-26-340271.

BioStem Technologies, Inc. (BSEM) is a biotechnology company listed on US.

BioStem Technologies, Inc. filed a 8-K on 2026-08-07. Accession 0001193125-26-340271.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BSEM revenue for 2026-06-30 was $7.9M. Net income was -$9.0M. Revenue was down 27.9% from 2025-06-30 to 2026-06-30. BSEM currently screens at market cap $211.2M.

Not investment advice. The BSEM SEC hub lists recent forms. The stock page is the research view.